Rahul Jandial, M.D., Ph.D.: Pediatric Neurosurgery Humanitarian Missions

March 13, 2018 | Denise Heady

Fourteen years ago, neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., began to travel to underserved countries to perform brain surgeries on disadvantaged children.

Continue Reading

Surprising Diagnosis Leads Skin Cancer Patient to City of Hope

May 29, 2018 | Robert Young

Barbara Dorfman ran a large nursery school for 25 years, helped raise five children and has enjoyed an exceptionally active lifestyle with her husband, but nothing could prepare her for the diagnosis she received four years ago.

Patient with Rare Skin Cancer Grateful for City of Hope Dermatology Team

May 22, 2018 | Robert Young

When what he thought was just a rash on his forehead spread to his face and neck, Joshua Singer sought medical help. After a number of treatments failed to figure out the problem, he turned to City of Hope, and renowned dermatologist Christiane Querfeld. M.D., Ph.D.

The Many Types of Skin Cancer: What You Should Know

May 21, 2018 | Kevin Chesley

Skin cancer is a largely survivable and curable form of cancer. Even its most rare and aggressive form, melanoma, has a high cure rate thanks to leading-edge treatments. But it’s still important to be careful, according to City of Hope Christiane Querfeld, M.D., Ph.D.

City of Hope to offer CAR T cell therapy for patients with the most common type of NHL

May 4, 2018 | Letisia Marquez

City of Hope recently announced that it is one of the first treatment centers certified in the United States to administer tisagenlecleucel CAR T cell therapy to adult patients with relapsed or refractory large B cell lymphoma.

Cheryl’s Story: CAR T Patient and Pioneer

April 30, 2018 | Letisia Marquez

Cheryl Wiers knew her cancer diagnosis happened for a reason, and for her, that reason could be her participation in a clinical trial using what is arguably the most promising cancer treatment — CAR T cell therapy.

City of Hope Researchers Find “Achilles' Heel” in B Cell Tumors

March 14, 2018 | Katie Neith

In a new paper published in the journal Cell, a team of researchers led by City of Hope’s Markus Müschen, M.D., Ph.D., and Gang Xiao, Ph.D., reports on the discovery of a new therapeutic target for these B cell malignancies.

‘Goldilocks’ Therapies Could Be a Breakthrough for Patients with Lymphoma

March 6, 2018 | City of Hope

Thanks to research being done by City of Hope's Markus Müschen, M.D., Ph.D., lymphoma patients may soon receive treatments that leverage quality control mechanisms that our own immune systems utilize to fight harmful antibodies.

5 Things to Know About Skin Cancer

February 5, 2018 | Kevin Chesley

Skin cancer is the most commonly diagnosed malignancy. Most forms are not life-threatening, except for the rarest form, melanoma. However, even this most aggressive form of skin cancer has a high cure rate, thanks to new leading-edge treatments.